Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Palleon Pharmaceuticals

Request full access

Leading biotechnology company

Waltham, United StatesFounded 2016Biotech & Life Sciences

About Palleon Pharmaceuticals

Palleon Pharmaceuticals is a biotechnology company focused on developing novel cancer therapies by targeting the Siglec Sialoglycan axis, a pathway that plays a critical role in immune suppression in tumors. The company operates in the oncology market, primarily serving patients with various forms of cancer. Palleon's business model revolves around the research and development of first-in-class medicines that aim to transform cancer treatment. Revenue is generated through partnerships, licensing agreements, and potentially future sales of approved therapies. The company's core technologies include the EAGLE and HYDRA platforms, which are designed to investigate and block tumor immunosuppressive glyco codes, thereby enhancing anticancer immunity. Palleon Pharmaceuticals is committed to advancing innovative treatments that can significantly improve patient outcomes.

Source: Dealroom company data

At a glance

Status
Operational
Employees
22
Open positions
None listed
Dealroom signal
67.3/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Oncology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BOther financing Sep 2020 $100M $400M Takeda Ventures · Abbvie Biotech Ventures · Citadel · Matrix Capital Management —
SERIES AOther financing Oct 2017 $48M $190M Abbvie Biotech Ventures · SR One · Takeda Ventures —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Palleon Pharmaceuticals website traffic

Latest recorded traffic for Palleon Pharmaceuticals is 5K monthly website visits, up 56.3% over the last three months. Palleon Pharmaceuticals's team declined 12% over the past year.

Latest monthly visits5K 3-month web change+56.3% 1-year team growth-12%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Palleon Pharmaceuticals in the Waltham ecosystem

Live from Dealroom

The Palleon Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A7 investors entered at this stage

  • SR One
  • Abbvie Biotech Ventures
  • Takeda Ventures
  • Citadel
  • Matrix Capital Management
  • Pfizer Ventures
  • Vertex Ventures HC

Other known investors2 additional known investors

  • King's College London
  • Stanford University
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Palleon Pharmaceuticals on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Palleon Pharmaceuticals’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.